Business context and reporting period
The filing is a Form 10-Q for the three months ended March 31, 2014. The supplied metadata identifies Westwater Resources, Inc., but the filing itself is for Uranium Resources, Inc. (URI); verify the issuer before relying on this summary. URI explored, developed and historically produced uranium, but none of its properties was in production during the period.
Financial performance and position
- Revenue: No uranium sales revenue in either first quarter of 2014 or 2013. URI said it invoiced Itochu about $264,000 for recovered yellowcake during Q1 2014, applied to remediation costs; payment was received April 30.
- Loss and expenses: Net loss was $3.46 million, compared with a restated $4.47 million loss in Q1 2013. Operating loss was $3.70 million versus $4.24 million. Basic and diluted loss per share was $0.15 versus $0.26. With no sales, a sales margin is not meaningful.
- Costs: Cost of uranium sales was $1.03 million, down from $1.56 million, primarily reflecting lower impairment and pond-recovery costs. General and administrative expense was nearly unchanged at $2.64 million. Q1 2014 included about $377,000 of non-recurring expenses, according to management.
- Cash flow: Operating cash use was $3.75 million, compared with $3.89 million. Investing cash flow was zero. Financing provided $13.24 million, principally from stock issuance and $2.0 million of convertible-loan proceeds. Cash rose to $10.61 million from $1.12 million at December 31, 2013.
- Balance sheet and liquidity: Total assets were $46.48 million and total liabilities were $12.96 million at March 31. Current assets were $11.72 million against current liabilities of $2.92 million. Restricted cash was $4.01 million. Cash was about $11.9 million on May 6.
- Debt: The RCF secured convertible facility carried 10% annual interest after January 29, 2014 and matured December 31, 2016. At March 31, the balance sheet reported a $1.71 million convertible-loan liability and a $3.07 million derivative liability; these carrying values reflect accounting for the conversion feature and debt discount. The facility was amended after quarter-end: RCF advanced a further $3.0 million on April 30, bringing total drawn to $8.0 million, with no further availability.
Material changes versus the prior comparable period
- Net loss narrowed by about $1.01 million, reflecting lower mineral-property costs and impairment charges and a $654,000 unrealized gain on the derivative liability.
- Cash increased substantially following equity financing and loan proceeds. Common shares outstanding rose from 19.82 million at year-end to 24.44 million at March 31.
- Q1 2013 comparative figures were restated after URI reclassified costs from property, plant and equipment to mineral-property expense.
Outlook, risks, contingencies and unusual items
- URI was not producing uranium, had no uranium inventory, and did not project significant sales revenue or related cash inflows for 2014. Management expected existing cash to fund planned operations through 2014; additional equity financing depended on market conditions, and a funding shortfall could require changes to business plans.
- The convertible loan’s conversion price was initially $2.60 per share and could be adjusted downward, subject to a $1.00 floor, for certain equity issuances before November 13, 2014. RCF held about 27% of outstanding shares as of May 9; conversion of the full $8.0 million at $2.60 would raise its ownership to about 35.1%.
- After quarter-end, URI settled former CFO Thomas Ehrlich’s lawsuit for $50,000 of legal fees and 119,231 shares; $360,000 had been accrued at March 31 based on the estimated settlement.
- Environmental restoration and reclamation estimates, uranium-property carrying values, permitting, uranium prices, financing access and regulatory changes are key uncertainties. URI reported no material changes to the risk factors in its 2013 Form 10-K. Management said disclosure controls were effective as of March 31, 2014.
Important facts for investors to verify
- Confirm the issuer: the filing is for Uranium Resources, Inc., not the company named in the request metadata.
- Review the April 2014 loan amendment and $3.0 million advance, including the resulting $8.0 million secured balance and conversion terms.
- Assess the cash runway against ongoing operating cash use and the absence of expected material 2014 sales.
- Check the settlement’s final accounting and share issuance, and the potential dilution from the convertible loan and further equity sales.
- Review the restated Q1 2013 statements and the assumptions underlying derivative-liability valuation and reclamation obligations.